Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
PURPOSE: Bladder cancer recurrence occurs in 40% of patients following radical cystectomy (RC) and pelvic lymphadenectomy (PLND). Although recurrence can be reduced with adjuvant chemotherapy, the toxicity and low response rates of this treatment restrict its use to patients at highest risk. We dev...
Auteurs principaux: | Catto, J, Abbod, M, Linkens, D, Larré, S, Rosario, D, Hamdy, F |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2009
|
Documents similaires
-
Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle‐Invasive Bladder Cancer in the United States
par: Bernard Bright Davies‐Teye, et autres
Publié: (2025-02-01) -
Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology
par: Vahid Mehrnoush, et autres
Publié: (2022-09-01) -
Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder
par: Wempy Supit, et autres
Publié: (2014-10-01) -
Comparative study of intelligent models for the prediction of bladder cancer progression.
par: Abbod, M, et autres
Publié: (2006) -
The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy
par: Jin Hyuck Kim, et autres
Publié: (2023-03-01)